NCT02933879View on ClinicalTrials.gov

Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

March 21, 2016

Primary Completion Date

March 6, 2018

Study Completion Date

June 21, 2018

Conditions
Onychomycosis
Interventions
DRUG

NVXT topical

topical treatment

DRUG

Placebo (Vehicle) Topical

Placebo (Vehicle) Topical

Trial Locations (1)

15219

Novum Pharmaceutical Research Services (Novum), Pittsburgh

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02933879 - Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study | Biotech Hunter | Biotech Hunter